| Lactose (India) Ltd | 120 Cr. | 95.1 | 205/84.3 | 26.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,638 Cr. | 334 | 479/192 | 75.4 | 24.3 | 0.20 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.2 Cr. | 43.4 | 87.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 58.7 Cr. | 40.1 | 41.0/17.0 | 140 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 64.6 Cr. | 85.8 | 119/69.7 | 17.5 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 54,583 Cr. | 1,935 | 2,286/1,275 | 21.7 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 317 Cr. | 13.1 | 17.2/10.8 | 19.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 17.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 808 Cr. | 1,505 | 1,999/635 | 27.9 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 90.1 Cr. | 18.0 | 32.0/17.0 | 24.6 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 974 Cr. | 331 | 449/219 | 8.69 | 133 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.92 Cr. | 13.9 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.47 Cr. | 3.00 | 8.28/2.11 | 4.24 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 403 Cr. | 415 | 536/211 | 60.9 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,979 Cr. | 1,144 | 1,565/944 | 45.0 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 49.1 Cr. | 0.24 | 1.12/0.23 | 3.23 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 35.0 Cr. | 13.3 | 26.3/11.4 | 17.1 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 8.10 Cr. | 8.02 | 15.8/8.01 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 157 Cr. | 439 | 851/419 | 8.88 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 76.0 Cr. | 76.0 | 92.5/26.1 | 143 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,874 Cr. | 1,231 | 2,452/1,226 | 40.0 | 174 | 0.84 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 22.8 Cr. | 49.8 | 88.7/36.1 | 49.4 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 19.2 Cr. | 128 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 70.6 Cr. | 129 | 144/9.41 | 48.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.9 Cr. | 41.0 | 73.0/33.0 | 49.9 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.43 Cr. | 21.4 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,648 Cr. | 441 | 1,028/441 | 21.7 | 72.4 | 0.26 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 73.5 Cr. | 17.0 | 29.6/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.4 Cr. | 22.5 | 39.3/17.4 | 49.6 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 86,621 Cr. | 2,098 | 2,727/2,082 | 52.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 230 Cr. | 400 | 524/241 | 23.6 | 123 | 1.13 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 63.2 Cr. | 44.0 | 47.9/26.7 | 98.7 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 64,948 Cr. | 1,118 | 1,279/994 | 19.0 | 603 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 144 Cr. | 231 | 303/159 | 137 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 713 Cr. | 71.2 | 115/70.1 | 18.4 | 32.6 | 2.12 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.4 Cr. | 24.1 | 42.8/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,006 Cr. | 1,589 | 1,902/919 | 58.1 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.91 Cr. | 0.59 | 1.14/0.51 | 97.5 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 194 Cr. | 25.3 | 53.8/24.0 | 12.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 6.86 Cr. | 11.7 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.60 | 6.57/2.82 | 307 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,367 Cr. | 27,467 | 37,000/25,260 | 38.7 | 1,888 | 1.77 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,134 Cr. | 787 | 972/557 | 29.8 | 226 | 0.65 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 181 Cr. | 63.7 | 100/31.3 | 50.5 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 3,994 Cr. | 1,204 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,853 Cr. | 1,345 | 1,870/1,110 | 398 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 636 Cr. | 182 | 330/154 | 14.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 61.2 Cr. | 7.38 | 29.4/7.36 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 969 Cr. | 725 | 849/270 | 15.3 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,636 Cr. | 374 | 791/374 | 18.1 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,414 Cr. | 1,002 | 1,402/975 | 20.0 | 768 | 1.00 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,34,827 Cr. | 3,982 | 4,125/2,886 | 62.2 | 250 | 0.80 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 731 Cr. | 79.5 | 259/78.6 | | 41.3 | 0.62 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,112 Cr. | 11.9 | 23.5/11.6 | 17.7 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 14,695 Cr. | 384 | 1,328/382 | 42.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,054 Cr. | 134 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,86,748 Cr. | 1,610 | 1,851/1,547 | 33.5 | 324 | 0.99 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,310 Cr. | 518 | 734/441 | 360 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,805 Cr. | 300 | 360/175 | 34.6 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,346 Cr. | 273 | 502/265 | 34.6 | 125 | 0.18 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,506 Cr. | 195 | 260/111 | 197 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,278 Cr. | 4,035 | 6,718/3,976 | 25.1 | 340 | 2.89 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,642 Cr. | 2,200 | 2,725/1,772 | 32.7 | 335 | 0.91 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,970 Cr. | 5,400 | 6,739/4,904 | 29.2 | 373 | 2.31 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 160 Cr. | 45.5 | 77.4/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,151 Cr. | 4,630 | 5,993/3,701 | 29.9 | 841 | 0.76 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 110 Cr. | 89.4 | 206/81.0 | 11.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,227 Cr. | 365 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,537 Cr. | 694 | 1,590/604 | 67.7 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,001 Cr. | 13,250 | 19,748/10,060 | 86.8 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 270 Cr. | 13.9 | 40.0/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,019 Cr. | 840 | 1,341/660 | 9.76 | 483 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,894 Cr. | 34.6 | 70.5/34.4 | 25.1 | 21.8 | 0.58 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,727 Cr. | 170 | 276/162 | 22.0 | 59.3 | 0.47 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 77.9 Cr. | 49.3 | 123/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 259 Cr. | 72.4 | 162/71.8 | 127 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 97,873 Cr. | 2,140 | 2,228/1,774 | 22.6 | 430 | 0.56 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 906 Cr. | 453 | 809/447 | 11.3 | 357 | 0.40 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,409 Cr. | 989 | 1,141/501 | 78.2 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,129 Cr. | 1,088 | 1,235/596 | 23.0 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 135 Cr. | 61.0 | 114/58.8 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 655 Cr. | 136 | 216/123 | 37.2 | 104 | 2.22 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 554 Cr. | 319 | 500/265 | 20.1 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 15,123 Cr. | 949 | 1,250/802 | 30.4 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,522 Cr. | 1,882 | 1,939/1,303 | 39.2 | 243 | 0.82 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,084 Cr. | 164 | 302/161 | 24.8 | 38.0 | 1.53 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,153 Cr. | 1,470 | 1,599/1,168 | 37.5 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,067 Cr. | 70.5 | 127/57.5 | 17.8 | 59.7 | 1.14 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 25.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 860 Cr. | 105 | 124/67.2 | 29.0 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,920 Cr. | 208 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,479 Cr. | 201 | 457/200 | 245 | 96.9 | 0.70 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,186 Cr. | 1,401 | 2,350/1,243 | 27.1 | 397 | 0.49 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,119 Cr. | 312 | 463/285 | 57.4 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,071 Cr. | 539 | 627/412 | 25.6 | 164 | 0.28 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,936 Cr. | 1,946 | 2,286/1,275 | 21.8 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 38,842 Cr. | 2,290 | 3,516/1,921 | 40.7 | 101 | 1.83 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,891 Cr. | 1,692 | 2,131/1,200 | 24.1 | 610 | 1.06 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,097 Cr. | 375 | 528/359 | 27.0 | 149 | 1.33 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,145 Cr. | 1,380 | 1,910/1,097 | 46.0 | 227 | 0.53 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 96,425 Cr. | 1,156 | 1,380/1,020 | 16.7 | 432 | 0.69 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,431 Cr. | 220 | 322/178 | 23.0 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,10,672 Cr. | 1,370 | 1,673/1,310 | 20.3 | 408 | 0.95 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,163 Cr. | 1,726 | 2,397/1,551 | 22.4 | 416 | 0.34 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 194 Cr. | 65.7 | 174/64.0 | 13.9 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,632 Cr. | 154 | 196/105 | 14.9 | 107 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 50.0 Cr. | 30.0 | 59.0/28.5 | 17.5 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,212 Cr. | 365 | 425/291 | 125 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,507 Cr. | 1,492 | 2,000/1,430 | 33.3 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 110 Cr. | 68.3 | 129/67.2 | 16.1 | 49.2 | 1.76 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 265 Cr. | 111 | 205/67.8 | 25.1 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 20,652 Cr. | 8,260 | 10,691/6,502 | 89.3 | 320 | 0.39 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,778 Cr. | 613 | 791/544 | 31.4 | 118 | 0.75 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 131 Cr. | 62.2 | 137/61.0 | 6.97 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,751 Cr. | 5,666 | 5,934/4,492 | 28.8 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,948 Cr. | 760 | 1,108/725 | 23.6 | 271 | 1.44 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 396 Cr. | 690 | 1,250/684 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,831 Cr. | 2,708 | 3,080/2,022 | 34.8 | 345 | 1.03 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,038 Cr. | 271 | 367/258 | 20.6 | 133 | 1.91 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,421 Cr. | 375 | 575/312 | 18.0 | 147 | 0.27 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,401.28 Cr | 1,083.31 | | 50.45 | 202.18 | 0.38% | 16.29% | 15.20% | 6.10 |